APONTIS PHARMA AG (DE:APPH)
XETRA:APPH
Germany Market
Holding DE:APPH?
Track your performance easily

APONTIS PHARMA AG (APPH) Financial Statements

7 Followers

APONTIS PHARMA AG Financial Overview

APONTIS PHARMA AG's market cap is currently ―. The company's EPS TTM is €-0.849; its P/E ratio is -11.49; APONTIS PHARMA AG is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Jun 22Dec 21Jun 21Dec 20
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments€ 36.35M€ 32.22M€ 29.84M€ 30.51M€ 8.06M
Total Assets€ 59.85M€ 57.74M€ 54.13M€ 54.38M€ 29.69M
Total Debt€ 0.00€ 0.00€ 0.00€ 0.00€ 0.00
Net Debt€ -36.35M€ -32.22M€ -29.84M€ -30.51M€ -8.06M
Total Liabilities€ 18.29M€ 15.55M€ 13.42M€ 15.12M€ 26.23M
Stockholders Equity€ 41.57M€ 42.19M€ 40.71M€ 39.26M€ 3.46M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in EUR

APONTIS PHARMA AG Earnings and Revenue History

APONTIS PHARMA AG Debt to Assets

APONTIS PHARMA AG Cash Flow

APONTIS PHARMA AG Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis